Pacific Biosciences Of California (PACB) EPS (Basic) Growth (1y) (2011 - 2026)
Pacific Biosciences Of California (PACB) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | -47.75% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 43.85% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 14.55% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | -25.84% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 42.13% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 72.17% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 13.85% |
| 10 | Pacific Biosciences Of California | 394.53 Mn | 157.66 Mn | 12.64 Mn | -3.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.10% |
| Mar 31, 2026 | 98.11% |
| Dec 31, 2025 | -1,658.11% |
| Sep 30, 2025 | 43.23% |
| Jun 30, 2025 | 78.05% |
| Mar 31, 2025 | -394.92% |
| Dec 31, 2024 | 102.67% |
| Sep 30, 2024 | 15.15% |
| Jun 30, 2024 | -127.86% |
| Mar 31, 2024 | 20.25% |
| Dec 31, 2023 | 13.95% |
| Sep 30, 2023 | 23.30% |
| Jun 30, 2023 | 12.19% |
| Mar 31, 2023 | 0.81% |
| Dec 31, 2022 | -10.65% |
| Jun 30, 2022 | 28.39% |
| Mar 31, 2022 | -87.76% |
| Dec 31, 2021 | -174.87% |
| Jun 30, 2021 | 99.92% |
| Mar 31, 2021 | 10.93% |